These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37302969)
61. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947 [TBL] [Abstract][Full Text] [Related]
62. Eosinophilic granulomatosis with polyangiitis masquerading as hemorrhagic vesiculobullous herpes simplex infection. Muradova E; Storonsky M; Ferenczi K; Santoro F Int J Dermatol; 2020 Dec; 59(12):e477-e480. PubMed ID: 32710554 [No Abstract] [Full Text] [Related]
63. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions. Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698 [TBL] [Abstract][Full Text] [Related]
64. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis. Frankel SK; Sullivan EJ; Brown KK Crit Care Clin; 2002 Oct; 18(4):855-79. PubMed ID: 12418444 [TBL] [Abstract][Full Text] [Related]
65. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review. Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685 [TBL] [Abstract][Full Text] [Related]
66. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment. Lally L; Spiera R Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936 [TBL] [Abstract][Full Text] [Related]
67. Eosinophilic granulomatosis with polyangitis: A new target for biologicals. Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309 [TBL] [Abstract][Full Text] [Related]
68. A case of omalizumab-associated eosinophilic granulomatosis with polyangiitis. Yamaki Y; Hayashi D; Honda K; Imai H; Takada H Pediatr Int; 2021 Sep; 63(9):1119-1121. PubMed ID: 34170601 [No Abstract] [Full Text] [Related]
70. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia? Duran E; Kilic L; Durhan G; Inkaya AÇ; Guven GS; Karakaya G; Ariyurek OM; Karadag O Ann Rheum Dis; 2023 Apr; 82(4):e85. PubMed ID: 32709679 [No Abstract] [Full Text] [Related]
71. Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence. Fanouriakis A; Kougkas N; Vassilopoulos D; Fragouli E; Repa A; Sidiropoulos P Semin Arthritis Rheum; 2015 Aug; 45(1):60-6. PubMed ID: 25908179 [TBL] [Abstract][Full Text] [Related]
72. Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature. Kai M; Vion PA; Boussouar S; Cacoub P; Saadoun D; Le Joncour A RMD Open; 2023 Sep; 9(3):. PubMed ID: 37673442 [TBL] [Abstract][Full Text] [Related]
73. Coronary vasospasm in eosinophilic granulomatosis with polyangiitis. Chapman FA; Dhaun N; Dweck M; Mills NL Rheumatology (Oxford); 2020 Dec; 59(12):e144-e146. PubMed ID: 32756991 [No Abstract] [Full Text] [Related]
74. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study. Nolasco S; Portacci A; Campisi R; Buonamico E; Pelaia C; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Crimi N; Scichilone N; Pelaia G; Carpagnano GE; Crimi C Front Immunol; 2023; 14():1204444. PubMed ID: 37457743 [TBL] [Abstract][Full Text] [Related]
75. A life-threatening presentation of eosinophilic granulomatosis with polyangiitis. Ammirati E; Cipriani M; Musca F; Bonacina E; Pedrotti P; Roghi A; Astaneh A; Schroeder JW; Nonini S; Russo CF; Oliva F; Frigerio M J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e109-e111. PubMed ID: 26556445 [TBL] [Abstract][Full Text] [Related]
76. Therapeutic immunomodulation in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Puéchal X Joint Bone Spine; 2016 Jan; 83(1):7-10. PubMed ID: 26639221 [No Abstract] [Full Text] [Related]
77. [Eosinophilic Granulomatosis with Polyangiitis with Pulmonary and Cardiac Involvement]. Kamp JC; Suhling H; Ramthor M; Hinrichs JB; Soudah B; Adel J; Welte T; Ringshausen FC Pneumologie; 2021 Jan; 75(1):33-38. PubMed ID: 32707588 [TBL] [Abstract][Full Text] [Related]
78. Refractory PR3-positive ANCA-associated vasculitis with eosinophilia requiring anti-IL-5 therapy: A case report. Anderson E; Friedman MA Mod Rheumatol Case Rep; 2023 Jun; 7(2):431-434. PubMed ID: 36527418 [TBL] [Abstract][Full Text] [Related]
79. Polyarteritis Nodosa and Eosinophilic Granulomatosis With Polyangiitis Presenting as Distal Extremity Muscular Edema and Pain. Kim JW; Mills B; Rashid H; Solow EB J Clin Rheumatol; 2021 Dec; 27(8S):S775-S776. PubMed ID: 32658049 [No Abstract] [Full Text] [Related]
80. Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose? Akdime F; Puéchal X; Roche N J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2942-2943. PubMed ID: 34246444 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]